Orlak v. Loyola University Health System

885 N.E.2d 999, 228 Ill. 2d 1, 319 Ill. Dec. 319, 2007 Ill. LEXIS 1837
CourtIllinois Supreme Court
DecidedDecember 28, 2007
Docket102534
StatusPublished
Cited by99 cases

This text of 885 N.E.2d 999 (Orlak v. Loyola University Health System) is published on Counsel Stack Legal Research, covering Illinois Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Orlak v. Loyola University Health System, 885 N.E.2d 999, 228 Ill. 2d 1, 319 Ill. Dec. 319, 2007 Ill. LEXIS 1837 (Ill. 2007).

Opinions

JUSTICE GARMAN

delivered the judgment of the court, with opinion.

Justices Freeman, Fitzgerald, and Karmeier concurred in the judgment and opinion.

Justice Kilbride specially concurred, with opinion.

Justice Burke dissented, with opinion.

Chief Justice Thomas took no part in the decision.

OPINION

In July 2002, plaintiff, Diane Orlak, sued defendant Loyola University Health System (Loyola) in the circuit court of Cook County, alleging that Loyola was liable to her for an alleged failure to notify her in a timely manner that she may have contracted hepatitis C (HCV) from a blood transfusion that she received in 1989 during hospitalization for injuries sustained in an accident. The circuit court granted Loyola’s motion to dismiss, finding that plaintiffs action was barred by the statute of repose contained in section 13 — 212(a) of the Code of Civil Procedure (Code) (735 ILCS 5/13 — 212(a) (West 2002)). The appellate court affirmed (No. 1 — 04—0401 (unpublished order under Supreme Court Rule 23)) and we granted plaintiffs petition for leave to appeal (210 Ill. 2d R. 315).

BACKGROUND

Plaintiff was hospitalized at Foster G. McGaw Hospital in Maywood, Illinois, in April and May 1989, for burns suffered during a work-related accident. During the course of her hospitalization, plaintiff was given a blood transfusion. Because plaintiff was unconscious at the time, her mother signed a consent form for the transfusion. That form stated in part, “In making such request and in giving such consent, I hereby acknowledge that I have been informed that there is no known definitive test for the determination of the existence or nonexistence of viral hepatitis in blood and that I fully understand that the transfusion or administration of blood or blood components to me may result in viral hepatitis or other untoward reactions.” Sometime in 1990, Loyola advised plaintiff to be tested for the presence of the human immunodeficiency virus (HIV). Plaintiff underwent testing and tested negative for the presence of the virus. In August 2000, Loyola notified plaintiff by letter that she should be tested for HCV because her blood donor had recently tested positive for the virus. After being tested, plaintiff learned that the test was positive for HCV

In her third amended complaint, plaintiff alleged that following Loyola’s advice to her in 1990 to be tested for HIV she reasonably believed that, after testing negative for that virus, the blood she had received was safe and free from deadly disease. She also took issue with Loyola’s statement in its August 2000 letter that at the time she received her blood transfusion, no reliable tests for HCV were available. She alleged that in 1996, the Food and Drug Administration (FDA) issued a memorandum to hospitals advising them to notify patients who received blood transfusions prior to 1992 to be tested for the presence of HCV Plaintiff also alleged that in 1997 the National Institutes of Health (NIH) published a “Consensus Development Conference Statement,” which found that HCV progresses at a slow rate with no symptoms in the majority of patients during the first 20 years after infection. The NIH also found that HCV patients who consume alcoholic beverages are at greater risk of rapidly developing cirrhosis of the liver and end-stage liver disease. The NIH recommended that individuals who had received blood transfusions prior to 1990 should be tested for HCV According to plaintiff, the NIH report was posted on the Internet in April 1997 and was published in the Journal of Hepatology in September 1997.

Plaintiff’s complaint contained counts alleging constructive fraud, medical negligence, medical battery, and ordinary negligence. In count I, for constructive fraud, plaintiff alleged that Loyola’s failure to inform her of the need to be tested for HCV at the time it advised her to be tested for HIV lulled her into a false sense of security that the blood she had received was free of disease. She alleged that her reliance in that regard was justifiable and reasonable. In count IV for ordinary negligence, plaintiff alleged that in 1996 and 1997 Loyola knew or should have known of the need for plaintiff to be tested for HCV and that, beginning in 1996, or at the latest in March 1997, Loyola owed plaintiff a duty of reasonable care to notify her that she had potentially contracted HCV through her blood transfusion and that she needed to be tested. Plaintiff also alleged that for every day thereafter that the duty existed, Loyola continued to breach its duty of care by failing to notify plaintiff of the potential for infection and the need to be tested.

Loyola filed a motion to dismiss all counts (735 ILCS 5/2 — 619(a)(5) (West 2002)) oh the ground that plaintiffs action was time-barred. Loyola argued that plaintiffs cause of action arose out of patient care stemming from her 1989 hospitalization and blood transfusion. Thus, the medical malpractice statute of repose (735 ILCS 5/13 — 212(a) (West 2002)) was applicable. Loyola argued that this applied as well to plaintiffs claims for constructive fraud and ordinary negligence. The circuit court agreed and dismissed plaintiffs complaint with prejudice.

The appellate court affirmed. With respect to plaintiffs ordinary negligence claim, the court rejected her argument that because she was no longer a patient and she challenged only the failure to timely give notice of the need for testing, her cause of action did not arise out of patient care. The appellate court also rejected plaintiffs constructive fraud and equitable estoppel claims. No. 1 — 04—0401 (unpublished order under Supreme Court Rule 23).

ANALYSIS

I

A motion to dismiss under section 2 — 619 of the Code admits the legal sufficiency of the complaint, but asserts some affirmative matter that defeats the claim. King v. First Capital Financial Services Corp., 215 Ill. 2d 1, 12 (2005). In ruling on the motion, the circuit court must interpret all pleadings and supporting documents in the light most favorable to the nonmoving party. Borowiec v. Gateway 2000, Inc., 209 Ill. 2d 376, 383 (2004). Our standard of review in this appeal is de novo. DeSmet v. County of Rock Island, 219 Ill. 2d 497, 504 (2006).

II

Plaintiff argues that the circuit and appellate courts erred in holding that the four-year medical malpractice statute of repose applies to bar her claim for ordinary negligence. That statute provides in part:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hamblin v. Ogunleye
2024 IL App (4th) 240645 (Appellate Court of Illinois, 2024)
Landers Children Family, LLC v. Rees
2024 IL App (4th) 230460-U (Appellate Court of Illinois, 2024)
Eberhardt v. Village of Tinley Park
2024 IL App (1st) 230139 (Appellate Court of Illinois, 2024)
Dalessandro v. Quinn-Dalessandro
2023 IL App (1st) 211119 (Appellate Court of Illinois, 2023)
Brandolino v. Schlak
N.D. Illinois, 2022
Pierce v. Wilner
N.D. Illinois, 2021
Kalina v. United States
S.D. Illinois, 2021
U.S. Bank National Ass'n v. Senese
2021 IL App (2d) 200302-U (Appellate Court of Illinois, 2021)
Cahnman v. Timber Court LLC
2021 IL App (1st) 200338 (Appellate Court of Illinois, 2021)
Kollross v. Goldstein
2021 IL App (1st) 200008 (Appellate Court of Illinois, 2021)
Malek v. Malek
N.D. Illinois, 2020
Islamic Center of Chicago Western Suburbs v. Fahmy
2020 IL App (2d) 190249-U (Appellate Court of Illinois, 2020)
Kesse v. Ford Motor Company
N.D. Illinois, 2020
Tagco, USA, Inc. v. Trend Global, LLC
2020 IL App (1st) 181318-U (Appellate Court of Illinois, 2020)
Lawler v. University of Chicago Medical Center
2017 IL 120745 (Illinois Supreme Court, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
885 N.E.2d 999, 228 Ill. 2d 1, 319 Ill. Dec. 319, 2007 Ill. LEXIS 1837, Counsel Stack Legal Research, https://law.counselstack.com/opinion/orlak-v-loyola-university-health-system-ill-2007.